Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
(2007) found that intranasally administered epithalon significantly activated neuron activity in the cerebral cortex of white rats, presenting findings that the peptide may be of interest in clinical applications for the treatment of CNS activity impairments [9]
In clinical studies, participants lost an average of 15% to 20% of their body weight over time
They belong to a class of medication called glucagon-like peptide (GLP-1) receptor agonists and are an effective weight loss tool for all ages as they: Suppress the appetite by boosting insulin production after you eat Interferes with Gluconeogenesis, thereby reducing both fasting as well as postprandial glucose Regulating the digestion process in the stomach by slowing down the movement of food Intimate the brain to tell your body that you are full It can help you shed up to two pounds per week when combined with physical activity and reduced caloric intake Medical Weight Loss Using Combination of GLP-1 and GIP Injections Combination of GLP-1 and GIP is an FDA-approved injectable medication used for medical weight loss that acts as both a GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor agonist
This infusion may support healthy aging, increase energy levels, and promote brain health by protecting against neurodegenerative changes
Injectable use: Subcutaneous injection 23 times per week is a typical protocol
The Stein Institute for Research on Aging plans to translate these findings into individualized aging dashboards that use epigenetic clocks to track biological aging
